| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2025 | Feb 27, 2025 | BridgeBio Pharma, Inc. | CFO | Sell | 26.3 | -8,500 | -7.66% | ✓ | $282.1K |
| Feb 16, 2025 | Feb 19, 2025 | BridgeBio Pharma, Inc. | CFO | Sell | 22.5 | -17,250 | -14.41% | ✓ | $607.2K |
| Jan 28, 2025 | Jan 30, 2025 | BridgeBio Pharma, Inc. | CFO | Sell | 5.0 | -68,000 | -42.04% | ✓ | $2.5M |
| Nov 19, 2024 | Nov 20, 2024 | BridgeBio Pharma, Inc. | CFO | Sell | 37.5 | -4,156 | -4.24% | ✓ | $93.1K |
| Nov 16, 2024 | Nov 19, 2024 | BridgeBio Pharma, Inc. | CFO | Sell | 20.0 | -13,077 | -11.78% | ✗ | $310.2K |
| Aug 16, 2024 | Aug 20, 2024 | BridgeBio Pharma, Inc. | CFO | Sell | 17.5 | -17,232 | -16.82% | ✓ | $421.7K |
| May 16, 2024 | May 17, 2024 | BridgeBio Pharma, Inc. | CFO | Sell | 20.0 | -13,943 | -15.42% | ✗ | $432.8K |
| Feb 16, 2024 | Feb 21, 2024 | BridgeBio Pharma, Inc. | CFO | Sell | 20.0 | -18,919 | -23.12% | ✗ | $704K |
| Nov 16, 2023 | Nov 20, 2023 | BridgeBio Pharma, Inc. | CFO | Sell | 5.0 | -44,996 | -55.07% | ✓ | $1.3M |
| Aug 16, 2023 | Aug 18, 2023 | BridgeBio Pharma, Inc. | CFO | Sell | 5.0 | -44,994 | -55.07% | ✓ | $1.3M |
| May 16, 2023 | May 18, 2023 | BridgeBio Pharma, Inc. | CFO | Sell | 7.5 | -44,996 | -55.27% | ✓ | $632K |
| May 3, 2023 | May 5, 2023 | BridgeBio Pharma, Inc. | CFO | Sell | 7.5 | -64,929 | -64.07% | ✓ | $920.7K |
| Apr 5, 2023 | Apr 7, 2023 | BridgeBio Pharma, Inc. | CFO | Sell | 7.5 | -55,500 | -35.39% | ✓ | $857.7K |
| Mar 3, 2023 | Mar 3, 2023 | BridgeBio Pharma, Inc. | CFO | Sell | 7.5 | -62,692 | -28.56% | ✓ | $687.1K |
| Feb 16, 2023 | Feb 21, 2023 | BridgeBio Pharma, Inc. | CFO | Sell | 22.5 | -27,627 | -11.18% | ✓ | $350.3K |
| Feb 3, 2023 | Feb 6, 2023 | BridgeBio Pharma, Inc. | CFO | Sell | 12.5 | -61,040 | -21.78% | ✓ | $671.9K |
| Jan 5, 2023 | Jan 6, 2023 | BridgeBio Pharma, Inc. | CFO | Sell | 17.5 | -61,040 | -17.89% | ✓ | $468.5K |
| Nov 16, 2022 | Nov 18, 2022 | BridgeBio Pharma, Inc. | CFO | Sell | 20.0 | -30,467 | -8.20% | ✗ | $289K |
| Aug 16, 2022 | Aug 18, 2022 | BridgeBio Pharma, Inc. | CFO | Sell | 22.5 | -9,227 | -2.63% | ✗ | $102.2K |
| May 16, 2022 | May 18, 2022 | BridgeBio Pharma, Inc. | Officer | Sell | 22.5 | -9,228 | -2.77% | ✗ | $62.2K |
| Feb 16, 2022 | Feb 18, 2022 | BridgeBio Pharma, Inc. | Officer | Sell | 45.0 | -1,020 | -0.33% | ✗ | $9K |
| Nov 16, 2021 | Nov 18, 2021 | BridgeBio Pharma, Inc. | Officer | Sell | 40.0 | -1,234 | -0.40% | ✗ | $58.3K |
| Aug 16, 2021 | Aug 18, 2021 | BridgeBio Pharma, Inc. | Officer | Sell | 40.0 | -1,028 | -0.34% | ✗ | $50.9K |
| May 16, 2021 | May 18, 2021 | BridgeBio Pharma, Inc. | Officer | Sell | 43.8 | -862 | -0.28% | ✗ | $46.3K |
| Feb 16, 2021 | Feb 18, 2021 | BridgeBio Pharma, Inc. | Officer | Buy | 90.0 | +7,408 | 2.53% | ✗ | $461.5K |
| Nov 16, 2020 | Nov 18, 2020 | BridgeBio Pharma, Inc. | Officer | Sell | 43.8 | -592 | -0.20% | ✗ | $26.2K |
| Aug 16, 2020 | Aug 18, 2020 | BridgeBio Pharma, Inc. | Officer | Sell | 43.8 | -591 | -0.20% | ✗ | $16.9K |
| Aug 3, 2020 | Aug 5, 2020 | BridgeBio Pharma, Inc. | Officer | Sell | 41.3 | -7,200 | -2.45% | ✓ | $196.3K |
| Jul 1, 2020 | Jul 6, 2020 | BridgeBio Pharma, Inc. | Officer | Sell | 35.0 | -10,800 | -3.54% | ✓ | $334.1K |
| Jun 8, 2020 | Jun 10, 2020 | BridgeBio Pharma, Inc. | Officer | Sell | 47.5 | -2,000 | -0.65% | ✓ | $60K |
| Jun 3, 2020 | Jun 5, 2020 | BridgeBio Pharma, Inc. | Officer | Sell | 51.3 | -1,600 | -0.52% | ✓ | $48.1K |
| Jun 1, 2020 | Jun 3, 2020 | BridgeBio Pharma, Inc. | Officer | Sell | 41.3 | -7,200 | -2.28% | ✓ | $211.4K |
| May 5, 2020 | May 6, 2020 | BridgeBio Pharma, Inc. | Officer | Sell | 45.0 | -5,706 | -1.77% | ✓ | $174K |
| May 1, 2020 | May 5, 2020 | BridgeBio Pharma, Inc. | Officer | Sell | 38.8 | -8,694 | -2.63% | ✓ | $255.3K |
| Apr 1, 2020 | Apr 3, 2020 | BridgeBio Pharma, Inc. | Officer | Sell | 41.3 | -7,200 | -2.13% | ✓ | $191.6K |
| Mar 2, 2020 | Mar 4, 2020 | BridgeBio Pharma, Inc. | Officer | Sell | 35.0 | -10,800 | -3.10% | ✓ | $348.5K |
| Feb 3, 2020 | Feb 5, 2020 | BridgeBio Pharma, Inc. | Officer | Sell | 35.0 | -10,800 | -3.01% | ✓ | $375.1K |
| Jan 2, 2020 | Jan 6, 2020 | BridgeBio Pharma, Inc. | Officer | Sell | 38.8 | -10,800 | -2.92% | ✓ | $355.7K |
| Jul 1, 2019 | Jul 3, 2019 | BridgeBio Pharma, Inc. | Officer | Buy | 97.5 | +55,500 | 17.73% | ✗ | $943.5K |